Draft Specialty Drug List Available for Comment, Responses Due March 17 The draft specialty drug list is now available for public comment. HHSC will accept comments until Friday, March 17. Upcoming clinical prior authorization changes: Olumiant - Scheduled for March 27 Antimigraine Agents (Triptans) - April 4 Calcitonin Gene-Related Peptide Receptor Antagonists - April 4

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202